Literature DB >> 29725873

Comment on: "A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis".

Ena Singh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29725873     DOI： 10.1007/s40273-018-0655-0

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  2 in total

1.  Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.

Authors:  William J Sandborn; Chinyu Su; Bruce E Sands; Geert R D'Haens; Séverine Vermeire; Stefan Schreiber; Silvio Danese; Brian G Feagan; Walter Reinisch; Wojciech Niezychowski; Gary Friedman; Nervin Lawendy; Dahong Yu; Deborah Woodworth; Arnab Mukherjee; Haiying Zhang; Paul Healey; Julian Panés
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

2.  A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis.

Authors:  Ewa Stawowczyk; Paweł Kawalec
Journal:  Pharmacoeconomics       Date:  2018-04       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.